PEPperPRINT GmbH participated in a webinar by Luke Marshall from Biotome Pty Ltd to walk through a stepwise workflow for converting broad PhIP-Seq discovery data into validated peptide biomarkers.
Public source
Publisher name
Public post
How do you identify real, reproducible autoantibody responses from a proteome-wide screen? 🌶️ In this webinar, Luke Marshall from Biotome Pty Ltd will walk through a st…
Company
PEPperPRINT GmbH
The leading provider of high-density peptide microarrays for antibody validation, epitope mapping & antigen discovery.
- Industry
- Biotechnology Research
- Location
- Heidelberg, DE
- Company size
- 11–50 employees
About PEPperPRINT GmbH
PEPperPRINT is an innovative biotech company from Heidelberg, Germany, and the leading provider of high density peptide and protein microarrays for antibody characterization or the fingerprint analysis of antibody responses from biological samples. The product and service portfolio was recently complemented by T cell epitope mapping and monitoring, making PEPperPRINT a one-stop solution provider for the fingerprint analysis of immune responses e.g. for epitope mapping, antibody biomarker discovery or the analysis of adverse immune effects. PEPperPRINT’s peptide microarrays and screening services have been used by researchers around the world with over 200 peer-reviewed publications.
See moreLatest activity
Latest activity from PEPperPRINT GmbH
4 signals
Presence & Recognition
PEPperPRINT GmbH is attending the 14th EuroMabNet Annual Meeting in Vilnius, Lithuania from September 10 to 11, 2026, to discuss antibody research and high-resolution peptide microarrays.
Research & Knowledge
PEPperPRINT GmbH contributed to a study in Advanced Science by using its peptide microarray technology to map the binding sites of two anti-Doppel antibodies, 4D6 and 5C7, and identify specific regions recognized by each antibody.
Research & Knowledge
PEPperPRINT GmbH's R&D team is developing glycopeptide microarrays to investigate antibody responses against glycosylated structures.
Discover more
Similar signals
Similar public activity from other companies.
Presence & Recognition
Bruker Cellular Analysis
Bruker Cellular Analysis participated in a webinar featuring researchers from Vanderbilt University exploring antibody discovery strategies for SARS-CoV-2 and hantaviruses.
Presence & Recognition
Quanterix
Quanterix hosted a webinar exploring how researchers can build and optimize high-plex biomarker panels to support emerging hypotheses, incorporate new biomarkers, and generate deeper biological insights.
Presence & Recognition
Alamar Biosciences, Inc.
Alamar Biosciences, Inc. is hosting a webinar on 16 September featuring Caroline Chan and Katharina Stracke discussing the NULISAseq Neuro 220 Panel and the Neuro 220 Pilot Program for researchers in Australia and New Zealand.
Presence & Recognition
Evosep Biosystems
Evosep Biosystems is hosting an upcoming webinar on Advancing Plasma Proteomics featuring Sindisiwe Buthelezi from CSIR, South Africa, discussing extracellular vesicle-enriched plasma proteomics and molecular signatures associated with pancreatic ductal adenocarcinoma in a South African patient cohort.
Presence & Recognition
EpiCypher, Inc.